Cell Biosci takes $15M to examine cell pathways

Cell Biosciences, maker of software and other tools to learn more about how cells move and interact, has brought in $15 million of an anticipated $17.6 million fourth round of funding, according to a filing with the SEC. Based in Santa Clara, Calif., the company is backed by Domain Associates, Latterell Venture Partners, Vertical Group, Wellcome Trust, Novo A/S and the Royal Bank of Canada.

Next Story: CyberHeart raises $3.6M for cardiac radiosurgery
Previous Story: Aperto bags $240K more for Wimax equipment